Oryzon Genomics S.A. (BME:ORY)
3.200
-0.050 (-1.54%)
At close: Dec 5, 2025
Oryzon Genomics Market Cap
Oryzon Genomics has a market cap or net worth of €252.33 million as of December 5, 2025. Its market cap has increased by 165.85% in one year.
Market Cap
252.33M
Enterprise Value
239.34M
Revenue
7.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
€3.20
Market Cap Chart
Since December 14, 2015, Oryzon Genomics's market cap has increased from 122.00M to 252.33M, an increase of 106.83%. That is a compound annual growth rate of 7.55%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 6.50B |
| Laboratorios Farmaceuticos Rovi | 3.07B |
| Almirall | 2.77B |
| Faes Farma | 1.49B |
| Pharma Mar | 1.29B |
| Clínica Baviera | 752.57M |
| Prim, S.A. | 235.67M |
| Laboratorio Reig Jofre | 221.38M |